AJO LP boosted its holdings in shares of Steris PLC (NYSE:STE) by 4,952.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 504,922 shares of the medical equipment provider’s stock after acquiring an additional 494,929 shares during the period. AJO LP owned 0.60% of Steris worth $64,645,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of STE. Advisory Services Network LLC grew its stake in shares of Steris by 26.0% in the fourth quarter. Advisory Services Network LLC now owns 427 shares of the medical equipment provider’s stock worth $45,000 after acquiring an additional 88 shares during the period. Executive Wealth Management LLC purchased a new position in shares of Steris in the fourth quarter worth approximately $47,000. Enlightenment Research LLC purchased a new position in shares of Steris in the fourth quarter worth approximately $53,000. Icon Wealth Partners LLC purchased a new position in shares of Steris in the first quarter worth approximately $83,000. Finally, Signaturefd LLC boosted its holdings in shares of Steris by 301.0% in the first quarter. Signaturefd LLC now owns 834 shares of the medical equipment provider’s stock worth $107,000 after buying an additional 626 shares during the last quarter. 83.38% of the stock is owned by institutional investors.
In other Steris news, VP Karen L. Burton sold 1,387 shares of the stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $133.89, for a total transaction of $185,705.43. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Walter M. Rosebrough, Jr. sold 119,000 shares of the stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $132.56, for a total transaction of $15,774,640.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 237,145 shares of company stock valued at $32,091,848. 2.36% of the stock is owned by insiders.
STE stock traded down $0.72 during mid-day trading on Wednesday, reaching $145.35. 482,077 shares of the stock traded hands, compared to its average volume of 476,902. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.27 and a quick ratio of 1.82. Steris PLC has a one year low of $99.14 and a one year high of $146.96. The firm has a market cap of $12.29 billion, a PE ratio of 29.72 and a beta of 0.96. The company has a 50-day simple moving average of $136.59.
Steris (NYSE:STE) last posted its quarterly earnings results on Monday, May 13th. The medical equipment provider reported $1.53 EPS for the quarter, topping the Zacks’ consensus estimate of $1.44 by $0.09. The firm had revenue of $768.00 million for the quarter, compared to analysts’ expectations of $738.87 million. Steris had a net margin of 10.93% and a return on equity of 13.34%. The business’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.24 earnings per share. As a group, equities analysts anticipate that Steris PLC will post 5.37 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Wednesday, June 12th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date of this dividend is Tuesday, June 11th. Steris’s dividend payout ratio (DPR) is presently 27.81%.
Several equities analysts have weighed in on STE shares. Zacks Investment Research downgraded shares of Steris from a “hold” rating to a “sell” rating in a report on Tuesday, March 19th. KeyCorp boosted their target price on shares of Steris from $135.00 to $138.00 and gave the stock an “overweight” rating in a report on Wednesday, May 15th. Stephens boosted their target price on shares of Steris from $135.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday, May 15th. Finally, JMP Securities boosted their target price on shares of Steris from $135.00 to $150.00 and gave the stock a “market outperform” rating in a report on Wednesday, May 22nd. Five equities research analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and an average price target of $148.20.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Further Reading: What is a recession?
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.